Navigation Links
Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172
Date:4/29/2008

said Dr. Ted W. Love, chairman and chief executive officer of Nuvelo. "We plan to launch a Phase 1b trial of bolus dosing followed by escalating infusion doses of NU172 later this quarter, which should enable us to quickly begin a Phase 2 study evaluating NU172 in medical or surgical procedures in the fourth quarter of 2008 or the first quarter of 2009."

According to the American Heart Association, more than 450,000 coronary artery bypass graft (CABG) procedures and more than 1.2 million percutaneous coronary interventions (PCIs) are performed annually in the United States. Heparin, which must be paired with its antitode protamine for reversal, is the current standard of care for anticoagulation in CABG surgeries and PCI.

About Aptamers and NU172

Aptamers are chemically synthesized single-stranded nucleic acids that form well-defined three-dimensional shapes, allowing them to bind target molecules in a manner that is conceptually similar to antibodies. Characteristics of aptamers include high specificity and affinity, and the ability to target protein-protein interactions.

NU172 is an aptamer designed to directly inhibit thrombin's ability to stimulate blood clot formation in the setting of medical procedures where human blood is exposed to foreign materials. Specifically, NU172 is being studied for use as a potential short-acting anticoagulant during procedures such as coronary artery bypass graft surgery and percutaneous interventions. Data from the Phase 1 trial and preclinical studies suggest that NU172 has the potential for predictable anticoagulant effects, rapid onset and offset of action, and avoidance of thrombocytopenia.

About Nuvelo and Archemix's Joint Collaborative Effort

In August 2006, Nuvelo expanded its collaboration with Archemix to develop and commercialize aptamers that have a short-acting anticoagulant effect. Under the agreement, Archemix is responsible for discovery of short-acting aptamers for use in
'/>"/>

SOURCE Nuvelo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent Therapeutic Activity in Oral Mucositis Models
2. Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
3. Nuvelo Initiates Phase 1 Clinical Trial of Thrombin Inhibitor, NU172
4. Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke
5. Nuvelo Announces Alfimeprase SONOMA-2 Catheter Occlusion Data Presentation Webcast and Conference Call
6. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
7. XTENT Announces First Quarter 2008 Financial Results
8. Neuralstem Announces Issuance of Core Technology Patent in Europe
9. ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment
10. PulmoBioTech Announces Details of Its Regulatory Approval Experiments
11. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... 24, 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... corporate overview and update at the Piper Jaffray 26 th ... 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time), at The ... . A live audio webcast of the presentation ... website at www.arenapharm.com . A replay of the presentation ...
(Date:11/24/2014)... - Milestone Pharmaceuticals, Inc. today announced data from a Phase ... Australia of MSP-2017, a novel calcium ... supraventricular tachycardia (PSVT).  The results demonstrated that an ... single doses up to and including 140 mg ... including rapid onset, and validating proof of concept ...
(Date:11/24/2014)... RATON, Fla. , Nov. 24, 2014  Marta Rendon, ... Medicine, Boca Raton , FL and international key ... physicians selected from the United States ... in Istanbul, Turkey . Here, at this ... meet West, as world renowned facial plastic surgery experts from ...
Breaking Medicine Technology:Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 3Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 2Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 3Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 2Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 3
... /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP ... the Company plans to release third quarter 2010 financial ... closes. The Company will hold a conference ... to discuss its results.  Listeners may access the call ...
... Pharmaceuticals, Inc. (Nasdaq: REGN ) will webcast ... Conference on Wednesday, November 10, 2010.  The presentation is ... Time).  The session may be accessed through the Company,s ... page.  An archived version of the presentation will be ...
Cached Medicine Technology:BMP Sunstone to Report Third Quarter 2010 Financial Results 2
(Date:11/24/2014)... (PRWEB) November 24, 2014 Global ... 6.19 billion by 2020, according to a new ... rates of cardiac arrhythmias clubbed with growing global ... this market. Though still in the budding stage, ... rise in usage rates in the recent times, ...
(Date:11/24/2014)... Residents of retirement communities in Ohio and Virginia ... TALENT, an annual online talent competition and showcase organized ... crooners, to seniors partying on a “night on the ... young. , “SENIORS GOT TALENT, while still having a ... always been about highlighting the vibrancy of being a ...
(Date:11/24/2014)... Westbury, New York (PRWEB) November 24, 2014 ... recently contacted by the Family and Children's Association ... products such as soap, shampoo, mouthwash and other such ... senior citizens who are home bound, living in nursing ... are intended to greatly enhance the well being of ...
(Date:11/24/2014)... CA (PRWEB) November 24, 2014 SafeHandles™ ... episode of Innovations with Ed Begley Jr, airing via ... was created to provide a passive, non-invasive, replaceable, and ... how SafeHandles™ incorporates custom-fit shrinkable sleeves and adhesives to ... , “At the core of SafeHandles is the ...
(Date:11/24/2014)... 2014 "My friend was killed when ... cross the street in his motorized wheelchair," said an ... I came up with this idea so that people ... He developed the Safety Lites to make a wheelchair ... The device ensures that motorists can see the wheelchair. ...
Breaking Medicine News(10 mins):Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 2Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 3Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 4Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 2Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 3Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 3Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2
... Breakfast alone may not be the solution to reducing ... selections// could prove beneficial in the battle against the ... ,Published monthly by the Institute of Food ... nutrition and metabolic research and translates it into food ...
... HIV-infected child, who was allegedly refused treatment by doctors ... US-based Indian crusader against medical negligence to support him., ... and a poor labourer, approached the People for Better ... after government hospitals allegedly refused to perform a surgery ...
... mechanism that anthrax bacteria use to elude the body’s ... to lessen the effect of anthrax bacterial species Bacillus ... ,For the last four years, Dr. Rowe Byers, professor ... microbiology, have worked on the project that led to ...
... caffeine content on cans and bottles of its flagship soda ... substance. ,The new labels, which coincide with the ... separately state "caffeine content: 25mg/8fl oz". ,The disclosure, ... comes as consumer and health groups increasingly petition for the ...
... has been dubbed 'Dr. No' for her stance against AIDS// ... , The minister had earned the ... to South Africa’s escalating AIDS problems. ,She ... combating AIDS, over antiretroviral drugs used all over the world. ...
... The Federation of American Hospitals has urged the cause ... insurance, underlining// the imperativeness of basic health coverage. ... might instigate a federal legislation mandating employees to avail ... or buy it of their own accord or accept ...
Cached Medicine News:Health News:NRI Fights for HIV Child Who was Refused Treatment 2Health News:Discovery Leads to Way to Curb Anthrax Effect 2Health News:Pepsi to Put Caffeine Content on Labels 2Health News:Dr. ‘NO’ Admitted for Lung Conditi 2
The Bledsoe Achilles Boot saves time by eliminating casting series required to stretch the achilles tendon during rehab....
Get back into action with MalleoLoc. Perfect for playing basketball, volleyball or everyday activities. The MalleoLoc stabilizing ankle brace increases ankle stability without restricting mobility....
DarcoGel™ Upper chamber is foam filled, conforms to calf; gel-filled lower chamber molds to the malleoli for a custom fit. Freeze the removable liner for cold therapy. One size. Fits left or ri...
Softsplint after bunion surgery. Hook-and-loop closure. Maintains hallux positioning and metatarsophalangeal alignment. Washable....
Medicine Products: